Celleo originated at the intersection of great biology and great engineering. Sparks fly at the intersection.

Our mission is to enable Cell & Gene Therapies to deliver population-level health outcomes, realizing the extraordinary potential of humanity’s most powerful therapeutic modality – our cells, augmented.

We contribute intelligent production systems for the manufacture of Cell & Gene Therapies.

Our 3 co-founders each bring nearly 20 years of deep industry experience in the development and production of Cell & Gene Therapies. Celleo develops GMP production systems in collaboration with leading commercial biotherapeutics players, developers of novel therapeutics at pre-clinical to clinical stage, CDMOs, and major university medical centers.

Our production systems seek to accommodate, not dictate, the diversity of processes, modalities and business models characteristic of our vibrant industry.

Steve Jobs predicted “…the biggest innovations of the 21st century will be at the intersection of biology and technology.”  Today’s Cell & Gene Therapy industry is approaching a tipping point – from a limited set of therapeutics changing the lives of a fortunate few, to a broadly available toolkit for physicians providing a new standard of personalized care.  We’re here to hasten that transition.

Millions of patients in need deserve it.

Thousands of Cell Therapy professionals deserve it too.